Ingredion

INGR · NYSE

$96.82+$0.55 (+0.57%)TodayMarket closed · Oct 20, 7:31 PM ET

Prev close $96.27

INGR analyst rating

HoldConsensus of 6 analysts over the last 12 months. 17% rate it a buy.

Strong buy0
Buy1
Hold5
Underperform0
Sell0

12-month price target · 10 analysts

Average $123.79 (+27.9% upside)

Low: $109.08
Now: $96.82
High: $151.78

Upgrades and downgrades

The latest rating actions, newest first

INGR analyst upgrades, downgrades and rating actions
Firm	Date	Action	Rating	Price target	Hit rate
Barclays	Oct 14, 2026	Maintains	Equal-Weight	$118.00 → $115.00	48%
UBS	Oct 5, 2026	Maintains	Neutral	$108.00 → $104.00	49%
UBS	Aug 5, 2026	Maintains	Neutral	$104.00 → $108.00	49%
Barclays	Aug 5, 2026	Maintains	Equal-Weight	$120.00 → $118.00	48%
Oppenheimer	Jun 9, 2026	Downgrade	Outperform → Perform	—	55%
Barclays	May 6, 2026	Maintains	Equal-Weight	$128.00 → $120.00	48%
Oppenheimer	Apr 22, 2026	Maintains	Outperform	$130.00 → $126.00	55%
UBS	Apr 9, 2026	Maintains	Neutral	$124.00 → $122.00	49%
Benchmark	Mar 17, 2026	Initiates	Buy	$130.00	34%
UBS	Feb 5, 2026	Maintains	Neutral	$119.00 → $124.00	49%

The case for and against

Updated Nov 28, 2024

Bull case

Ingredion's financial performance demonstrates a robust upward trajectory, with operating profit increasing by 17.2% year-over-year to $143 million, supported by an improved operating margin of 12.0%, which is up 200 basis points from the previous year. Notably, the APAC segment achieved a remarkable 65.2% increase in operating income, reaching $38 million, accompanied by a significant operating profit margin improvement of 570 basis points to 13.9%. The company maintains a positive outlook for fiscal year 2023, projecting an operating income increase of 20% to 25%, driven by an effective pricing strategy that outpaces lower volumes and rising costs.

Bear case

Ingredion's financial outlook is negatively impacted by a significant decline in sales and operating income across its segments, with operating income for the specialty ingredients segment falling by 4.5% year-over-year and the core ingredients segment experiencing a substantial 33.3% decrease. The company's overall sales in South America also reflected a decline, with reported figures down 8.2% year-over-year, indicating potential weakness in key markets. Additionally, the observed trends in declining sweetener consumption due to health-focused consumer preferences could pose further risks to Ingredion’s revenue streams and profitability moving forward.

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.